chr19-41967744-C-T
Variant summary
Our verdict is Pathogenic. The variant received 25 ACMG points: 25P and 0B. PS1PS3PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_152296.5(ATP1A3):c.2839G>A(p.Gly947Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004047695: Experimental studies have shown that this missense change leads to a reduction in the ATPase activity of the Na+, K+-ATPase α3 subunit encoded by the ATP1A3 gene (Weigand KM et al., 2014)." and additional evidence is available in ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G947W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_152296.5 missense
Scores
Clinical Significance
Conservation
Publications
- alternating hemiplegia of childhood 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- ATP1A3-associated neurological disorderInheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
- cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Genomics England PanelApp
- developmental and epileptic encephalopathy 99Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- dystonia 12Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Genomics England PanelApp
- encephalopathy, acute, infection-inducedInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- alternating hemiplegia of childhoodInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 25 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_152296.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP1A3 | MANE Select | c.2839G>A | p.Gly947Arg | missense | Exon 21 of 23 | NP_689509.1 | P13637-1 | ||
| ATP1A3 | c.2878G>A | p.Gly960Arg | missense | Exon 21 of 23 | NP_001243143.1 | P13637-3 | |||
| ATP1A3 | c.2872G>A | p.Gly958Arg | missense | Exon 21 of 23 | NP_001243142.1 | P13637-2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP1A3 | MANE Select | c.2839G>A | p.Gly947Arg | missense | Exon 21 of 23 | ENSP00000498113.1 | P13637-1 | ||
| ENSG00000285505 | n.2839G>A | non_coding_transcript_exon | Exon 21 of 25 | ENSP00000494711.1 | A0A2R8YEY8 | ||||
| ATP1A3 | TSL:2 | c.2878G>A | p.Gly960Arg | missense | Exon 21 of 23 | ENSP00000444688.1 | P13637-3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at